Recruiting Neuroendocrine Tumors Studies in Birmingham
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
This phase II trial compares the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) to the usual approach of treatment with everolimus, sunitinib, or cabozantinib i...
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
This phase II trial studies the effect of lutetium Lu 177 dotatate compared to the usual treatment (everolimus) in treating patients with somatostatin receptor positive bronchial neuroendocrine tumors...
About Neuroendocrine Tumors Clinical Trials in Birmingham
Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.
There are currently 2 neuroendocrine tumors clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 170 participants. Research is being sponsored by National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuroendocrine Tumors Clinical Trials in Birmingham — FAQ
Are there neuroendocrine tumors clinical trials in Birmingham?
Yes, there are 2 neuroendocrine tumors clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What neuroendocrine tumors treatments are being tested?
The 2 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.
Data updated March 2, 2026 from ClinicalTrials.gov